Abstract
Physicians generally believe that antimicrobial drugs are widely effective and fairly harmless. Most physicians also have the vague feeling that if one antimicrobial drug is good, two should be better, and three should cure almost everybody of everything. This attitude may be responsible for the widespread use of antimicrobial drugs in combinations. At Johns Hopkins Hospital, 11% of 7094 patients admitted during a three-month period in 1963 received from two to five antimicrobial drugs (Cluff et al., 1964). Since that time several scientific and medical organizations have strongly opposed the widespread use of fixed combinations of antimicrobial drugs (A. M. A. Council on Drugs, 1970; Natl. Res. Council, 1969). In fact, fixed combinations have been removed from the market in the United States by action of the Food and Drug Administration. No evidence exists, however, that the prescribing of several antimicrobials simultaneously has diminished. It is therefore appropriate to reexamine the experimental basis of combined antimicrobial drug action and the clinical situations in which such combined antimicrobial action might be necessary or harmful. This review draws heavily on experimental work of our own group in the Department of Microbiology, University of California, San Francisco, and on previous summaries prepared by us (Jawetz and Gunnison, 1953; Jawetz, 1967; Jawetz, 1968). The literature in this field is vast and a complete survey is impractical. Therefore, only representative individual papers are cited.
This chapter was completed in January 1972.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
A.M. A. Council on Drugs: Fixed-dose combinations of drugs. J. Amer. med. Ass. 213, 1172–1175 (1970).
Beaty, H.N., Turck, M., Petersdorf, R. G.: Activity of broad spectrum antibiotics against enterococci and their efficacy in enterococcal endocarditis. Ann. N.Y. Acad. Sci. 145, 464–471 (1967).
Ben-Maimon, Rabbi Moses: The preservation of youth. New York: Philosophical Library 1958.
Blount, J.G.: Bacterial endocarditis. Amer. J. Med. 38, 909–922 (1965).
Bryant, R.E., Hood, A.F., Hood, C.E., Koenig, M.G.: Factors affecting mortality of gram negative rod bacteremia. Arch, intern. Med. 127, 120–128 (1971).
Bulger, R.J.: In-vitro activity of cephalothin/kanamycin and methicillin/kanamycin combinations against methicillin-resistant Staphylococcus aureus. Lancet 1967 I, 17–19.
Bulger, R. J., Kirby, W.M.M.: Gentamicin and ampicillin: synergism with other antibiotics. Amer. J. med. Sci. 246, 717–726 (1963).
Bulger, R. J., Roosen-Runge, U.: Bactericidal activity of the ampicillin/kanamycin combination against Escherichia coli, enterobacter-klebsiella, and proteus. Amer. J. med. Sci. 258, 7–13 (1969).
Cattell, W.R., Chamberlain, D. A., Fry, I.K., McSherry, M.A, Broughton, C., O’Grady, F.: Long-term control of bacteriuria with trimethoprim-sulfonamide. Brit. med. J. 1971I, 377–379.
Chang, T.W., Weinstein, L.: Inhibitory effects of other antibiotics on bacterial morphologic changes induced by penicillin G. Nature (Lond.) 211, 763–765 (1966).
Cluff, L.E., Thornton, G.F., Seidl, L.G.: Studies on the epidemiology of adverse drug reactions. I. Methods of surveillance. J. Amer. med. Ass. 188, 976–983 (1964).
Cohn, M.L, Middlebrook, G., Russell, W.R., Jr.: Combined drug treatment of tuberculosis. I. Prevention of emergence of mutant populations of tubercle bacilli resistant to both streptomycin and isoniazid in vitro. J. clin. Invest. 38, 1349–1355 (1959).
Donno, L., Sanguineti, V., Ricciabdi, M.L., Soldati, M.: Antimalarial activity of Kelfizina-trimethoprim and Kelfizina-pyrimethamine versus chloroquine in field trials in Nigeria. Amer. J. trop. Med. Hyg. 18, 182–187 (1969).
Dowling, H.F.: Present status of therapy with combinations of antibiotics. Amer. J. Med. 39, 796–803 (1965).
Eickhoff, T.C.: In vitro effects of carbenicillin combined with gentamicin or polymyxin B against Pseudomonas aeruginosa. Appl. Microbiol. 18, 469–473 (1969).
Eyles, D.E., Coleman, N.: An evaluation of the curative effects of pyrimethamine and sulfadiazine, alone and in combination, on experimental mouse toxoplasmosis. Antibiot. and Chemother. 5, 529–539 (1955).
Feldman, H.A.: Toxoplasmosis. New Engl. J. Med. 279, 1370–1375 (1968a).
Feldman, H.A.: Toxoplasmosis (concluded). New Engl. J. Med. 279, 1431–1437 (1968b).
Fbaher, M.A., Jawetz, E.: Combined action of β-lactamase-resistant and β-lactamase-susceptible penicillins on 20 strains of Psevdomonas aeruginosa. Antimicrob. Agents Chemother. (Annual) 711–715 (1967).
Gabbod, L.P., Watebwobth, P.M.: Methods of testing combined antibiotic bactericidal action and the significance of the results. J. clin. Path. 15, 328–338 (1962).
Goodman, L.S., Gilman, A. (Eds.): The pharmacological basis of therapeutics, 3rd. ed. New York: Macmillan 1965.
Gotoff, S.P., Behbman, R.E.: Neonatal septicemia. J. Pediat. 76, 142–153 (1970).
Gbeenfield, S., Feingold, D.S.: The synergistic action of the sulfonamides and the polymyxins against Serratia marcescens. J. infect. Dis. 121, 555–558 (1970).
Gunnison, J.B., Kunishige, E., Coleman, V.R., Jawetz, E.: The mode of action of antibiotic synergism and antagonism: the effect in vitro on bacteria not actively multiplying. J. gen. Microbiol. 13, 509–518 (1955).
Gunnison, J. B., Speck, R.S., Jawetz, E., Bbuff, J.A.: Studies on antibiotic synergism and antagonism: the effect of sulfadiazine on the action of penicillin in vitro and in vivo. Antibiot. and Chemother. 1, 259–266 (1951).
Hahn, F.E., Wisseman, C.L. Jr.: Inhibition of adaptive enzyme formation by antimicrobial agents. Proc. Soc. exp. Biol. (N.Y.) 76, 533–535 (1951).
Heaton, A.D., Russell, W. F., Jr., Denst, J., Middlebbook, G.: Combined drug treatment of tuberculosis. IV. Bacteriologic studies on the sputum and resected pulmonary lesions of tuberculosis patients. J. clin. Invest. 38, 1376–1383 (1959).
Hewitt, W.L., Seligman, S.J., Deigh, R.A.: Kinetics of the synergism of penicillin-streptomycin and penicillin-kanamycin for enterococci and its relationship to L-phase variants. J. Lab. clin. Med. 67, 792–807 (1966).
Hitchings, G.H.: Folate antagonists as antibacterial and antiprotozoal agents. Ann. N.Y. Acad. Sci. (Monogr.) 186, 444–451 (1971).
Hodgin, U.G., Sanfobd, J.P.: Gram-negative rod bacteremia. An analysis of 100 patients. Amer. J. Med. 39, 952–960 (1965).
Hunteb, T.H., Patebson, P.Y.: Bacterial endocarditis. D. M. 1–48 (1956).
Jawetz, E.: Assay of antibacterial activity in serum. Amer. J. Dis. Child. 103, 81–84 (1962).
Jawetz, E.: Combined antibiotic action: Some definitions and correlations between laboratory and clinical results. Antimicrob. Agents Chemother. (Annual) 203–209 (1967).
Jawetz, E.: The use of combinations of antimicrobial drugs. Ann. Rev. Pharmacol. 8, 151–170 (1968).
Jawetz, E., Bbainebd, H.D.: Staphylococcal endocarditis: results of combined antibiotic therapy in fourteen consecutive cases (1956–1959). Amer. J. Med. 32, 17–24 (1962).
Jawetz, E., Gunnison, J.B.: Antibiotic synergism and antagonism: an assessment of the problem. Pharmacol. Rev. 5, 175–192 (1953).
Jawetz, E., Gunnison, J.B., Coleman, V.R.: The combined action of penicillin with streptomycin or Chloromycetin on enterococci in vitro. Science 111, 254–256 (1950).
Jawetz, E., Gunnison, J.B., Coleman, V.R., Kempe, H.C.: A laboratory test for bacterial sensitivity to combinations of antibiotics. Amer. J. clin. Path. 25, 1016–1031 (1955).
Jawetz, E., Gunnison, J.B., Speck, R.S.: Studies on antibiotic synergism and antagonism: the interference of aureomycin, chloramphenicol, and terramycin with the action of streptomycin. Amer. J. med. Sci. 222, 404–412 (1951).
Jawetz, E., Sonne, M.: Penicillin-streptomycin treatment of enterococcal endocarditis. A re-evaluation. New Engl. J. Med. 274, 710–715 (1966).
Kamat, S.A.: Evaluation of therapeutic efficacy of trimethoprim-sulfamethoxazole and chloramphenicol in enteric fever. Brit. med. J. 1970 III, 320–322.
Kaye, D., Koenig, M.G., Hook, E.W.: The action of certain antibiotics and antibiotic combinations against Proteus mirabilis with demonstration of in vitro synergism and antagonism. Amer. J. med. Sci. 242, 320–330 (1961).
Klein, M., Kimmelman, L.J.: The correlation between the inhibition of drug resistance and synergism in streptomycin and penicillin. J. Bact. 54, 363–370 (1947).
Koenig, M.G., Kaye, D.: Enterococcal endocarditis. Report of nineteen cases with long-term follow-up data. New Engl. J. Med. 264, 257–264 (1961).
Lepper, M.H., Dowling, H.P.: Treatment of pneumococcic meningitis with penicillin compared with penicillin plus aureomycin: studies including observations on an apparent antagonism between penicillin and aureomycin. Arch. intern. Med. 88, 489–494 (1951).
Lepper, M.H., Dowling, H.F., Jackson, G.G., Spies, H.W., Mellody, M.: A comparison of the effect of two antibiotics (novobiocin and spiramycin) used in combination with that of spiramycin alone on the antibiotic sensitivity of Micrococcus pyogenes. J. Lab. clin. Med. 48, 920–921 (1956).
Mandel, W., Heaton, A.D., Russell, W.F., Jr., Middlebrook, G.: Combined drug treatment of tuberculosis. II. Studies of antimicrobially-active isoniazid and streptomycin serum levels in adult tuberculosis patients. J. clin. Invest. 38, 1356–1365 (1959).
Mandell, G.L., Lindsey, E., Hook, E.W.: Synergism of vancomycin and streptomycin for enterococci. Amer. J. med. Sci. 259, 346–349 (1970).
Mathies, A.W., Jr., Leedom, J.M., Ivler, D., Wehrle, P.F., Portnoy, B.: Antibiotic antagonism in bacterial meningitis. Antimicrob. Agents Chemother. (Annual) 218–224 (1967).
McCabe, W.R.: Clinical use of combinations of antimicrobial agents. Antimicrob. Agents Chemother. (Annual) 225–233 (1967).
Mccabe, W.R., Jackson, G.G.: Treatment of pyelonephritis. Bacterial, drug, and host factors in success or failure among 252 patients. New Engl. J. Med. 272, 1037–1044 (1965).
Medoff, G., Comfort, M., Kobayashi, G.S.: Synergistic action of amphotericin B and 5-fluorocytosine against yeast-like organisms. Proc. Soc. exp. Biol. (N.Y.) 138, 571–574 (1971).
Miles, C.P., Coleman, V.R., Gunnison, J.B., Jawetz, E.: Antibiotic synergism requires the simultaneous presence of both members of a synergistic drug pair. Proc. Soc. exp. Biol. (N.Y.) 78, 738–741 (1951).
Moellering, R.C., Jr., Weinberg, A.N.: Studies on antibiotic synergism against enterococci. II. Effect of various antibiotics on the uptake of 14C-labeled streptomycin by enterococci. J. clin. Invest. 50, 2580–2584 (1971).
Moellering, R.C., Jr., Wennersten, C., Weinberg, A.N.: Studies on antibiotic synergism against enterococci. I. Bactériologie studies. J. Lab. clin. Med. 77, 821–828 (1971).
National Research Council Division of Medical Sciences Drug Efficacy Study (National Academy of Sciences): Fixed combinations of antimicrobial agents. New Engl. J. Med. 280, 1149–1154 (1969).
Noone, P., Pattison, J.R.: Therapeutic implications of interaction of gentamicin and penicillins. Lancet 1971 II, 575–578.
Olsson, R.A., Kirby, J.C., Romansky, M.J.: Pneumococcal meningitis in the adult. Clinical, therapeutic, and prognostic aspects in forty-three patients. Ann. intern. Med. 55, 545–549 (1961).
Plotz, P.H., Davis, B.D.: Synergism between streptomycin and penicillin: a proposed mechanism. Science 135, 1067–1068 (1962).
Rahal, J.J., Jr., Meyers, B.R., Weinstein, L.: Treatment of bacterial endocarditis with cephalothin. New Engl. J. Med. 279, 1305–1309 (1968).
Robbins, W.C., Tompsett, R.: Treatment of enterococcal endocarditis and bacteremia. Amer. J. Med. 10, 278–299 (1951).
Rowley, D., Cooper, P.D., Roberts, P.W., Smith, E.L.: The site of action of penicillin. I. Uptake of penicillin on bacteria. Biochem. J. 46, 157–161 (1950).
Russell, W. F., Jr., Kass, L, Heaton, A.D., Dressler, S.H., Middlebrook, G.: Combined drug treatment of tuberculosis. III. Clinical application of the principles of appropriate and adequate chemotherapy to the treatment of pulmonary tuberculosis. J. clin. Invest. 38, 1366–1375 (1959).
Sabath, L.D., Abraham, E.P.: Synergistic action of penicillins and cephalosporins against Pseudomonas pyocyanea. Nature (Lond.) 204, 1066–1069 (1964).
Sabath, L.D., Elder, H.A., McCall, C.E., Finland, M.: Synergistic combinations of penicillins in the treatment of bacteriuria. New Engl. J. Med. 277, 232–238 (1967).
Schimpfe, S., Satterlee, W., Young, V.M., Serpick, A.: Empiric therapy with carbenicillin and gentamicin for febrile patients with cancer and granulocytopenia. New Engl. J. Med. 284, 1061–1065 (1971).
Schlichter, J. G., MacLean, H.: A method of determining the effective therapeutic level in the treatment of subacute bacterial endocarditis with penicillin. Amer. Heart J. 34, 209–211 (1947).
Smith, C.B., Dans, P.E., Wilfert, J.N., Finland, M.: Use of gentamicin in combinations with other antibiotics. J. infect. Dis. 119, 370–377 (1969).
Sonne, M., Jawetz, E.: Combined action of carbenicillin and gentamicin on Pseudomonas aeruginosa in vitro. Appl. Microbiol. 17, 893–896 (1969).
Standiford, H.D., de Maine, J. B., Kirby, W.M.M.: Antibiotic synergism of enterococci. Arch, intern. Med. 126, 255–259 (1970).
Ström, J.: Penicillin and erythromycin singly and in combination in scarlatina therapy and the interference between them. Antibiot. and Chemother. 11, 694–697 (1961).
Sutherland, R., Batchelor, F.R.: Synergistic activity of penicillins against penicillinase-producing gram-negative bacilli. Nature (Lond.) 201, 868–869 (1964).
Tan, J.S., Terhune, C.A., Jr., Kaplan, S., Hamburger, M.: Successful two-week treatment schedule for penicillin-susceptible Streptococcus viridans endocarditis. Lancet 1971 II, 1340–1343.
Wallace, J. F., Smith, R. H., Garcia, M., Petersdorf, R.G.: Studies on the pathogenesis of meningitis. VI. Antagonism between penicillin and chloramphenicol in experimental pneumococcal meningitis. J. Lab. clin. Med. 70, 408–418 (1967).
Watanakunakorn, C.: Penicillin combined with gentamicin or streptomycin: synergism against enterococci. J. infect. Dis. 124, 581–586 (1971).
Wilkowske, C. J., Facklam, R.R., Washington, II J. A., Geraci, J.E.: Antibiotic synergism: enhanced susceptibility of Group D streptococci to certain antibiotic combinations. Antimicrob. Agents Chemother. (Annual) 195–200 (1970).
Winters, R.E., Chow, A. W., Hecht, R.H., Hewitt, W.L.: Combined use of gentamicin and carbenicillin. Ann. intern. Med. 75, 925–927 (1971).
Zimmermann, R.A., Moellering, R.C., Jr., Weinberg, A.N.: Enterococcal resistance to antibiotic synergism. Antimicrob. Agents Chemother. (Annual) 517–521 (1970).
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1975 Springer-Verlag Berlin · Heidelberg
About this chapter
Cite this chapter
Jawetz, E. (1975). Combined Actions of Antimicrobial Drugs. In: Gillette, J.R., Mitchell, J.R. (eds) Concepts in Biochemical Pharmacology. Handbuch der experimentellen Pharmakologie / Handbook of Experimental Pharmacology, vol 28 / 3. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-46314-3_14
Download citation
DOI: https://doi.org/10.1007/978-3-642-46314-3_14
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-46316-7
Online ISBN: 978-3-642-46314-3
eBook Packages: Springer Book Archive